• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L-positive T cells in Peyer's patches by FTY720-induced lymphocyte homing.新型免疫抑制剂FTY720通过加速大鼠淋巴细胞归巢诱导循环成熟淋巴细胞滞留,III. FTY720诱导的淋巴细胞归巢使派尔集合淋巴结中CD62L阳性T细胞频率增加。
Immunology. 1998 Dec;95(4):591-4. doi: 10.1046/j.1365-2567.1998.00639.x.
2
FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.新型免疫抑制剂FTY720通过加速大鼠淋巴细胞归巢诱导循环成熟淋巴细胞滞留。I. FTY720通过加速淋巴细胞归巢选择性降低循环成熟淋巴细胞数量。
J Immunol. 1998 May 15;160(10):5037-44.
3
The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches.鞘氨醇-1-磷酸类似物FTY720通过高内皮微静脉对T细胞归巢进行差异性调节:T细胞表达的鞘氨醇-1-磷酸受体1(S1P1)在外周淋巴结中可增强整合素激活,但在派伊尔结中则不然。
Blood. 2005 Aug 15;106(4):1314-22. doi: 10.1182/blood-2004-09-3687. Epub 2005 May 3.
4
FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing.新型免疫抑制剂FTY720通过加速淋巴细胞归巢诱导循环淋巴细胞滞留。
Transplant Proc. 1999 Feb-Mar;31(1-2):1230-3. doi: 10.1016/s0041-1345(98)01975-7.
5
Evidence that FTY720 induces T cell apoptosis in vivo.FTY720在体内诱导T细胞凋亡的证据。
Immunopharmacology. 2000 Jun;48(1):75-85. doi: 10.1016/s0162-3109(00)00181-8.
6
B and T lymphocyte subsets enter peripheral lymph nodes and Peyer's patches without preference in vivo: no correlation occurs between their localization in different types of high endothelial venules and the expression of CD44, VLA-4, LFA-1, ICAM-1, CD2 or L-selectin.B淋巴细胞和T淋巴细胞亚群在体内无偏好地进入外周淋巴结和派尔集合淋巴结:它们在不同类型的高内皮微静脉中的定位与CD44、VLA-4、LFA-1、ICAM-1、CD2或L-选择素的表达之间不存在相关性。
Eur J Immunol. 1994 Oct;24(10):2312-6. doi: 10.1002/eji.1830241008.
7
Differential effects of single dose FTY720 on CD62L+ B-cells in stable renal allograft recipients.单剂量FTY720对稳定期肾移植受者CD62L+ B细胞的不同作用。
Int Immunopharmacol. 2007 Jan;7(1):88-95. doi: 10.1016/j.intimp.2006.08.018. Epub 2006 Sep 26.
8
L-selectin is not essential for naive CD4 cell trafficking or development of primary responses in Peyer's patches.L-选择素对于初始CD4细胞在派尔集合淋巴结中的迁移或初级免疫反应的发展并非必不可少。
Eur J Immunol. 1997 May;27(5):1140-6. doi: 10.1002/eji.1830270514.
9
Efficient lymphocyte migration across high endothelial venules of mouse Peyer's patches requires overlapping expression of L-selectin and beta7 integrin.小鼠派尔集合淋巴结高内皮微静脉处高效的淋巴细胞迁移需要L-选择素和β7整合素的重叠表达。
J Immunol. 1998 Dec 15;161(12):6638-47.
10
A novel immunosuppressant, FTY720, induces peripheral lymphodepletion of both T- and B cells and immunosuppression in baboons.一种新型免疫抑制剂FTY720可导致狒狒外周血T细胞和B细胞耗竭并产生免疫抑制作用。
Transpl Immunol. 1999 Sep;7(3):149-57. doi: 10.1016/s0966-3274(99)80034-3.

引用本文的文献

1
p21-Activated Kinase 1 (Pak1) as an Element in Functional and Dysfunctional Interplay Among the Myocardium, Adipose Tissue, and Pancreatic Beta Cells.p21激活激酶1(Pak1)作为心肌、脂肪组织和胰腺β细胞之间功能与功能失调相互作用的一个因素。
Compr Physiol. 2025 Apr;15(2):e70006. doi: 10.1002/cph4.70006.
2
Arginine vasopressin hormone receptor antagonists in experimental autoimmune encephalomyelitis rodent models: A new approach for human multiple sclerosis treatment.精氨酸加压素激素受体拮抗剂在实验性自身免疫性脑脊髓炎啮齿动物模型中的应用:一种治疗人类多发性硬化症的新方法。
Front Neurosci. 2023 Mar 14;17:1138627. doi: 10.3389/fnins.2023.1138627. eCollection 2023.
3
Risk of cervical pre-cancer and cancer in women with multiple sclerosis exposed to high efficacy disease modifying therapies.暴露于高效疾病修正疗法的多发性硬化症女性患宫颈癌前病变和癌症的风险。
Front Neurol. 2023 Feb 10;14:1119660. doi: 10.3389/fneur.2023.1119660. eCollection 2023.
4
A Requirement of Protein Geranylgeranylation for Chemokine Receptor Signaling and Th17 Cell Function in an Animal Model of Multiple Sclerosis.蛋白香叶基香叶基化对于多发性硬化症动物模型中趋化因子受体信号和 Th17 细胞功能的需求。
Front Immunol. 2021 Mar 22;12:641188. doi: 10.3389/fimmu.2021.641188. eCollection 2021.
5
Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders.芬戈莫德:多发性硬化症和其他疾病治疗的经验教训和新机遇。
Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:149-170. doi: 10.1146/annurev-pharmtox-010818-021358.
6
Mechanism of Siponimod: Anti-Inflammatory and Neuroprotective Mode of Action.西尼莫德的作用机制:抗炎和神经保护作用模式。
Cells. 2019 Jan 7;8(1):24. doi: 10.3390/cells8010024.
7
Fingolimod modulates T cell phenotype and regulatory T cell plasticity in vivo.芬戈莫德在体内调节 T 细胞表型和调节性 T 细胞的可塑性。
J Autoimmun. 2019 Jan;96:40-49. doi: 10.1016/j.jaut.2018.08.002. Epub 2018 Aug 16.
8
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.多发性硬化症的肠道屏障:对病理生理学和治疗的影响。
Brain. 2018 Jul 1;141(7):1900-1916. doi: 10.1093/brain/awy131.
9
The novel sphingosine-1-phosphate receptors antagonist AD2900 affects lymphocyte activation and inhibits T-cell entry into the lymph nodes.新型鞘氨醇-1-磷酸受体拮抗剂AD2900影响淋巴细胞活化并抑制T细胞进入淋巴结。
Oncotarget. 2017 Jun 27;8(32):53563-53580. doi: 10.18632/oncotarget.18626. eCollection 2017 Aug 8.
10
T Cell Trafficking through Lymphatic Vessels.T细胞通过淋巴管的迁移。
Front Immunol. 2016 Dec 21;7:613. doi: 10.3389/fimmu.2016.00613. eCollection 2016.

本文引用的文献

1
FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.新型免疫抑制剂FTY720通过加速大鼠淋巴细胞归巢诱导循环成熟淋巴细胞滞留。II. FTY720通过减少T细胞向移植物中的浸润而非体内细胞因子的产生来延长皮肤同种异体移植物的存活时间。
J Immunol. 1998 Jun 1;160(11):5493-9.
2
FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.新型免疫抑制剂FTY720通过加速大鼠淋巴细胞归巢诱导循环成熟淋巴细胞滞留。I. FTY720通过加速淋巴细胞归巢选择性降低循环成熟淋巴细胞数量。
J Immunol. 1998 May 15;160(10):5037-44.
3
Potent immunosuppressants, 2-alkyl-2-aminopropane-1,3-diols.强效免疫抑制剂,2-烷基-2-氨基丙烷-1,3-二醇。
J Med Chem. 1996 Oct 25;39(22):4451-9. doi: 10.1021/jm960391l.
4
Lyphocyte migration in L-selectin-deficient mice. Altered subset migration and aging of the immune system.L-选择素缺陷小鼠中的淋巴细胞迁移。免疫系统亚群迁移改变与衰老。
J Immunol. 1996 Aug 1;157(3):1096-106.
5
Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720.通过新型免疫抑制剂FTY720治疗实现同种异体移植大鼠和犬的长期移植物接受。
Transplant Proc. 1996 Jun;28(3):1375-6.
6
FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A.FTY720,一种具有独特机制的新型免疫抑制剂。III. 与环孢素A联合使用对犬肾同种异体移植存活时间的协同延长作用。
Transplant Proc. 1996 Apr;28(2):1062-3.
7
FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.FTY720,一种具有独特机制的新型免疫抑制剂。II. 大鼠异位心脏同种异体移植中长期移植物存活的诱导及与环孢素A联合使用的协同效应。
Transplant Proc. 1996 Apr;28(2):1060-1.
8
FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats.FTY720,一种具有独特机制的新型免疫抑制剂。I. 延长大鼠皮肤同种异体移植存活时间及与环孢素联合使用的协同效应。
Transplant Proc. 1996 Apr;28(2):1056-9.
9
A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation.一种具有独特作用机制的新型免疫抑制剂FTY720,可诱导大鼠和犬同种异体移植长期接受移植器官。
Transplantation. 1996 Jan 27;61(2):200-5. doi: 10.1097/00007890-199601270-00006.
10
Lymphocyte homing and homeostasis.淋巴细胞归巢与内环境稳定。
Science. 1996 Apr 5;272(5258):60-6. doi: 10.1126/science.272.5258.60.

新型免疫抑制剂FTY720通过加速大鼠淋巴细胞归巢诱导循环成熟淋巴细胞滞留,III. FTY720诱导的淋巴细胞归巢使派尔集合淋巴结中CD62L阳性T细胞频率增加。

FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L-positive T cells in Peyer's patches by FTY720-induced lymphocyte homing.

作者信息

Yanagawa Y, Masubuchi Y, Chiba K

机构信息

Research Laboratories, Yoshitomi Pharmaceutical Industries Ltd, Iruma, Saitama, Japan.

出版信息

Immunology. 1998 Dec;95(4):591-4. doi: 10.1046/j.1365-2567.1998.00639.x.

DOI:10.1046/j.1365-2567.1998.00639.x
PMID:9893050
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1364357/
Abstract

FTY720, a novel immunosuppressant, sequesters circulating mature lymphocytes, especially T cells, within lymph nodes and Peyer's patches by accelerating lymphocyte homing, and thereby causes lymphocyte depletion in the blood. The FTY720-induced acceleration of lymphocyte homing appears to be mediated by lymphocyte homing receptors including CD62L, CD49d/beta7, and CD11a/CD18. In this study, expressions of CD62L, CD49d and CD11a on T cells in the peripheral blood, lymph nodes and Peyer's patches were analysed by flow cytometry in rats given FTY720 (1 mg/kg) orally. FTY720 markedly decreased the number of peripheral blood T cells, while not affecting CD62L, CD49d and CD11a expressions at 1-3 hr after administration. In contrast, both the frequency of CD62L-positive T cells and intensity of CD62L expression on T cells were increased in Peyer's patches but not lymph nodes at 3 hr after administration of FTY720. CD49d and CD11a expressions on T cells were unaffected by FTY720 in both Peyer's patches and lymph nodes at the same point in time. On the other hand, analysis of lymphocyte homing with calcein-labelled lymphocytes and anti-CD62L monoclonal antibody (mAb) confirmed that FTY720 predominantly increased CD62L-dependent lymphocyte homing to Peyer's patches. These findings indicate that FTY720 increases the frequency of CD62L-positive T cells by accelerating CD62L-predominant homing in Peyer's patches.

摘要

新型免疫抑制剂FTY720通过加速淋巴细胞归巢,使循环中的成熟淋巴细胞,尤其是T细胞,滞留在淋巴结和派尔集合淋巴结内,从而导致血液中的淋巴细胞减少。FTY720诱导的淋巴细胞归巢加速似乎是由包括CD62L、CD49d/beta7和CD11a/CD18在内的淋巴细胞归巢受体介导的。在本研究中,通过流式细胞术分析了口服FTY720(1mg/kg)的大鼠外周血、淋巴结和派尔集合淋巴结中T细胞上CD62L、CD49d和CD11a的表达。FTY720显著降低了外周血T细胞的数量,而在给药后1-3小时不影响CD62L、CD49d和CD11a的表达。相反,在给予FTY720后3小时,派尔集合淋巴结中CD62L阳性T细胞的频率和T细胞上CD62L的表达强度增加,但淋巴结中未增加。在同一时间点,派尔集合淋巴结和淋巴结中T细胞上的CD49d和CD11a表达均不受FTY720影响。另一方面,用钙黄绿素标记的淋巴细胞和抗CD62L单克隆抗体(mAb)对淋巴细胞归巢进行分析证实,FTY720主要增加了依赖CD62L的淋巴细胞向派尔集合淋巴结的归巢。这些发现表明,FTY720通过加速派尔集合淋巴结中以CD62L为主的归巢,增加了CD62L阳性T细胞的频率。